| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.10M | 15.14M | 8.90M | 4.25M | 3.38M | 327.30K |
| Gross Profit | 3.23M | 1.67M | 2.43M | -789.45K | -1.19M | -1.06M |
| EBITDA | 1.55M | 1.61M | 107.19K | -1.63M | -2.04M | -856.03K |
| Net Income | 15.91K | 15.91K | -734.41K | -1.68M | -2.33M | -923.72K |
Balance Sheet | ||||||
| Total Assets | 26.10M | 26.10M | 26.92M | 11.96M | 12.67M | 12.97M |
| Cash, Cash Equivalents and Short-Term Investments | 2.58M | 2.58M | 3.49M | 2.00M | 4.00M | 7.45M |
| Total Debt | 7.40M | 7.40M | 7.91M | 2.80M | 1.22M | 494.99K |
| Total Liabilities | 10.37M | 10.37M | 11.42M | 3.80M | 2.98M | 1.10M |
| Stockholders Equity | 15.73M | 15.73M | 15.49M | 8.17M | 9.69M | 11.87M |
Cash Flow | ||||||
| Free Cash Flow | 552.57K | 552.57K | 470.83K | -1.74M | -3.43M | -2.73M |
| Operating Cash Flow | 955.97K | 955.97K | 644.44K | -1.34M | -2.12M | -2.45M |
| Investing Cash Flow | -1.36M | -1.36M | -3.78M | -435.18K | -1.34M | 1.33M |
| Financing Cash Flow | -510.87K | -510.87K | 4.62M | -227.25K | 12.87K | 6.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
53 Neutral | AU$37.37M | ― | <0.01% | ― | 70.19% | ― | |
48 Neutral | AU$63.46M | -1.80 | ― | ― | ― | 7.16% | |
45 Neutral | AU$50.22M | -33.33 | ― | ― | ― | 96.00% | |
44 Neutral | AU$24.64M | -0.45 | -87.86% | ― | ― | -727.17% | |
42 Neutral | AU$15.86M | -8.47 | -4.46% | ― | ― | 4.49% | |
40 Underperform | AU$18.15M | -1.98 | -106.72% | ― | 90.14% | 52.54% |
Parkway Corporate Limited has disclosed a change in director Penelope Creswell’s interests, noting that she now holds 2.5 million unquoted performance rights in the company, expiring on 1 December 2035, where previously she held none. The update reflects a correction to the expiry date of the performance rights grant that was approved by shareholders at the company’s 26 November 2025 annual general meeting, clarifying the terms of Creswell’s equity-based remuneration and providing greater transparency for investors regarding director incentives and alignment with long-term shareholder value.
The most recent analyst rating on (AU:PWN) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Parkway Corporate Limited stock, see the AU:PWN Stock Forecast page.
Parkway Corporate Limited has reported that non-executive director Stephen van der Sluys has ceased serving on the company’s board as of 12 January 2026. He holds no Parkway securities in his own name, but retains an indirect interest via his self-managed superannuation fund, which holds 2.5 million unquoted performance rights expiring on 1 December 2035, and he has no interests in any related contracts. The filing formalises his departure and clarifies his remaining exposure to the company through outstanding performance rights, information relevant to investors tracking board changes and director-linked securities.
The most recent analyst rating on (AU:PWN) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Parkway Corporate Limited stock, see the AU:PWN Stock Forecast page.
Parkway Corporate Limited has announced the immediate retirement of Non-Executive Chairman Stephen van der Sluys, who has led the board since September 2022 after joining in August that year. He is credited by the company with overseeing a period of rapid growth, advancement of key technology milestones and the company’s recent transition to profitability. Non-Executive Director Ayten Saridas has been appointed Interim Non-Executive Chair while the board undertakes a renewal process to identify additional independent non-executive directors to support its next phase of growth, signalling continued evolution of the company’s governance structure in line with its expanding operations and strategic ambitions.
The most recent analyst rating on (AU:PWN) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Parkway Corporate Limited stock, see the AU:PWN Stock Forecast page.
Parkway Corporate Limited has announced a change in the interests of its director, Stephen van der Sluys, involving the acquisition of 2,500,000 unquoted performance rights set to expire on December 1, 2025. This change, approved at the company’s annual general meeting on November 26, 2025, reflects a strategic move to align the director’s interests with the company’s long-term performance goals, potentially impacting the company’s governance and stakeholder confidence.
The most recent analyst rating on (AU:PWN) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Parkway Corporate Limited stock, see the AU:PWN Stock Forecast page.
Parkway Corporate Limited has announced the issuance of 7,500,000 unquoted performance rights, set to expire 10 years from the grant date, as part of a previously announced transaction. This move is part of Parkway’s strategic initiatives to enhance its equity structure, potentially impacting its market positioning and providing long-term incentives for stakeholders.
The most recent analyst rating on (AU:PWN) stock is a Hold with a A$0.01 price target. To see the full list of analyst forecasts on Parkway Corporate Limited stock, see the AU:PWN Stock Forecast page.
Parkway Corporate Limited announced that all resolutions proposed at their 2025 Annual General Meeting were successfully passed. This includes key resolutions such as the approval of the remuneration report, re-election of directors, and the issuance of performance rights to non-executive directors. The approval of these resolutions is indicative of strong shareholder support and is expected to positively impact the company’s governance and strategic initiatives.
Parkway Corporate Limited has announced the issuance of 980,000 fully paid ordinary shares as of November 17, 2025. This move was made without disclosure to investors under Part 6D.2 of the Corporations Act, and the company confirms compliance with relevant provisions of the Corporations Act. The announcement has been approved by the company’s Board of Directors.
Parkway Corporate Limited has announced the issuance of 980,000 ordinary fully paid securities, which will be quoted on the ASX as of November 17, 2025. This move is part of the company’s strategy to enhance its financial standing and market position, potentially impacting its stakeholders by increasing the liquidity and attractiveness of its shares.
Parkway Corporate Limited reported strong quarterly performance with record free cash flow and ongoing strategic investments to enhance its engineering solutions capabilities. The company secured a 10-hectare site for its QBMC project and is progressing with formal approvals and feasibility activities. Parkway’s Industrial Operations division generated $3.62 million in operating revenue, contributing to a group EBITDA of $0.46 million, supported by specialized project execution activities. The company is building a project team for the QBMC project and scheduled an investor webinar to discuss its progress.
Parkway Corporate Limited announced a proposed issue of 7,500,000 unquoted performance rights, set to expire 10 years from the grant date, with a proposed issue date of December 10, 2025. This move is part of a placement or other type of issue, as the company seeks to enhance its financial strategies and potentially improve its market positioning.
Parkway Corporate Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled to be held virtually on November 26, 2025. The company has opted to provide the Notice of Meeting and related materials electronically, encouraging shareholders to participate and vote online. This approach reflects Parkway’s commitment to leveraging technology for enhanced shareholder engagement and operational efficiency.
Parkway Corporate Limited has announced that its Annual General Meeting (AGM) will be held virtually on November 26, 2025. Shareholders are encouraged to participate and vote, with the meeting set to discuss the company’s annual reports and a resolution on the remuneration report. The AGM is a significant event for stakeholders as it provides an opportunity to review the company’s financial performance and governance practices, potentially impacting future strategic decisions.